Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × carmofur × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

durvalumab 11 Bevacizumab 11 Nivolumab 8 pembrolizumab 7 tremelimumab 6 lenvatinib 6 fludarabine 6 Cyclophosphamide 6 atezolizumab 5 Sorafenib 4 Radiosurgery 4 Cisplatin 4 toripalimab 3 regorafenib 3 Ipilimumab 3 Gemcitabine 3 fludarabine phosphate 2 camrelizumab 2 apatinib 2 X-Rays 2 Riluzole 2 Radiotherapy 2 Photons 2 Magnetic Resonance Imaging 2 Lidocaine 2 Biopsy 2 zimberelimab 1 trastuzumab deruxtecan 1 tocilizumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07321613 2026-01-07

Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

Shanghai Zhongshan Hospital

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡